Deciphera Pharmaceuticals (DCPH)
(Delayed Data from NSDQ)
$25.59 USD
0.00 (0.00%)
Updated Jun 10, 2024 04:00 PM ET
3-Hold of 5 3
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
[DCPH]
Reports for Purchase
Showing records 1 - 20 ( 99 total )
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
All Is GIST Fine, While Waiting For "Vim" US and EU Filings For TGCT; Reit Buy and $30 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for DCPH 112123
Provider: Stock Traders Daily
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Investors Feel Positive E"MOTION" Towards Vimseltinib and Qinlock
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A